These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


311 related items for PubMed ID: 10665657

  • 1. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
    [Abstract] [Full Text] [Related]

  • 2. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
    Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
    [Abstract] [Full Text] [Related]

  • 3. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K, Tanigawara Y, Komada F, Nishiguchi K, Sakaeda T, Okumura K.
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [Abstract] [Full Text] [Related]

  • 4. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
    Takara K, Sakaeda T, Kakumoto M, Tanigawara Y, Kobayashi H, Okumura K, Ohnishi N, Yokoyama T.
    Oncol Res; 2009 Dec; 17(11-12):527-33. PubMed ID: 19806783
    [Abstract] [Full Text] [Related]

  • 5. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line, LLC-PK1.
    Ito T, Yano I, Tanaka K, Inui KI.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):955-60. PubMed ID: 9262363
    [Abstract] [Full Text] [Related]

  • 6. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
    Kakumoto M, Sakaeda T, Takara K, Nakamura T, Kita T, Yagami T, Kobayashi H, Okamura N, Okumura K.
    Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479
    [Abstract] [Full Text] [Related]

  • 7. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
    Tanaka K, Hirai M, Tanigawara Y, Ueda K, Takano M, Hori R, Inui K.
    Biochem Pharmacol; 1997 Mar 07; 53(5):741-6. PubMed ID: 9113094
    [Abstract] [Full Text] [Related]

  • 8. Interaction of digoxin with antihypertensive drugs via MDR1.
    Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K.
    Life Sci; 2002 Feb 15; 70(13):1491-500. PubMed ID: 11895100
    [Abstract] [Full Text] [Related]

  • 9. Effects of Kaempferia parviflora extracts and their flavone constituents on P-glycoprotein function.
    Patanasethanont D, Nagai J, Yumoto R, Murakami T, Sutthanut K, Sripanidkulchai BO, Yenjai C, Takano M.
    J Pharm Sci; 2007 Jan 15; 96(1):223-33. PubMed ID: 17031860
    [Abstract] [Full Text] [Related]

  • 10. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
    Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y.
    Drug Metab Pharmacokinet; 2008 Jan 15; 23(5):340-6. PubMed ID: 18974611
    [Abstract] [Full Text] [Related]

  • 11. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil.
    Higashi H, Watanabe N, Tamura R, Taguchi M.
    Biol Pharm Bull; 2017 Jan 15; 40(8):1314-1319. PubMed ID: 28769012
    [Abstract] [Full Text] [Related]

  • 12. Effects of P-glycoprotein inhibitors on cadmium accumulation in cultured renal epithelial cells, LLC-PK1, and OK.
    Endo T, Kimura O, Sakata M.
    Toxicol Appl Pharmacol; 2002 Dec 15; 185(3):166-71. PubMed ID: 12498733
    [Abstract] [Full Text] [Related]

  • 13. Outward transfer of dopamine precursor L-3,4-dihydroxyphenylalanine (L-dopa) by native and human P-glycoprotein in LLC-PK(1) and LLC-GA5 col300 renal cells.
    Soares-Da-Silva P, Serrão MP.
    J Pharmacol Exp Ther; 2000 May 15; 293(2):697-704. PubMed ID: 10773046
    [Abstract] [Full Text] [Related]

  • 14. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
    Honda Y, Ushigome F, Koyabu N, Morimoto S, Shoyama Y, Uchiumi T, Kuwano M, Ohtani H, Sawada Y.
    Br J Pharmacol; 2004 Dec 15; 143(7):856-64. PubMed ID: 15504753
    [Abstract] [Full Text] [Related]

  • 15. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep 15; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 16. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, Saito H.
    Biol Pharm Bull; 2009 Sep 15; 32(9):1588-93. PubMed ID: 19721237
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.
    Kusunoki N, Takara K, Tanigawara Y, Yamauchi A, Ueda K, Komada F, Ku Y, Kuroda Y, Saitoh Y, Okumura K.
    Jpn J Cancer Res; 1998 Nov 15; 89(11):1220-8. PubMed ID: 9914792
    [Abstract] [Full Text] [Related]

  • 18. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers.
    Wils P, Phung-Ba V, Warnery A, Lechardeur D, Raeissi S, Hidalgo IJ, Scherman D.
    Biochem Pharmacol; 1994 Oct 07; 48(7):1528-30. PubMed ID: 7945455
    [Abstract] [Full Text] [Related]

  • 19. Effect of PCB-126 on intracellular accumulation and transepithelial transport of vinblastine in LLC-PK1 and its transformant cells expressing human P-glycoprotein.
    Sasawatari S, Toki M, Horie T, Nakano Y, Ikeda T, Ueda K, Fujise H.
    J Vet Med Sci; 2004 Sep 07; 66(9):1079-85. PubMed ID: 15472471
    [Abstract] [Full Text] [Related]

  • 20. MDR1-mediated interaction of digoxin with antiarrhythmic or antianginal drugs.
    Kakumoto M, Takara K, Sakaeda T, Tanigawara Y, Kita T, Okumura K.
    Biol Pharm Bull; 2002 Dec 07; 25(12):1604-7. PubMed ID: 12499648
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.